Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern
Donal Skelly, Adam Harding, Javier Gilbert‐Jaramillo, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 168

Showing 1-25 of 168 citing articles:

The T cell immune response against SARS-CoV-2
Paul Moss
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 186-193
Open Access | Times Cited: 1085
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
Thibault Fiolet, Yousra Kherabi, Conor-James MacDonald, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 202-221
Open Access | Times Cited: 820
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
Rebecca P. Payne, Stephanie Longet, James Austin, et al.
Cell (2021) Vol. 184, Iss. 23, pp. 5699-5714.e11
Open Access | Times Cited: 314
Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis
Baoqi Zeng, Le Gao, Qingxin Zhou, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 234
The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines
Gary R. McLean, Jeremy P. Kamil, Benhur Lee, et al.
mBio (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 174
T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study
Adrienn Angyal, Stéphanie Longet, Shona C. Moore, et al.
The Lancet Microbe (2021) Vol. 3, Iss. 1, pp. e21-e31
Open Access | Times Cited: 160
Robust induction of B cell and T cell responses by a third dose of inactivated SARS-CoV-2 vaccine
Yihao Liu, Qin Zeng, Caiguanxi Deng, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 122
Association Between Menstrual Cycle Length and Coronavirus Disease 2019 (COVID-19) Vaccination
Alison Edelman, Emily R. Boniface, Eleonora Benhar, et al.
Obstetrics and Gynecology (2022)
Open Access | Times Cited: 116
T Cell Responses to SARS-CoV-2
Alessandro Sette, John Sidney, Shane Crotty
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 343-373
Closed Access | Times Cited: 114
SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies
Kevin W. Ng, Nikhil Faulkner, Katja Finsterbusch, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 655
Open Access | Times Cited: 84
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease
Eleanor Barnes, Carl S. Goodyear, Michelle Willicombe, et al.
Nature Medicine (2023) Vol. 29, Iss. 7, pp. 1760-1774
Open Access | Times Cited: 80
Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs
Meriem Bekliz, Kenneth Adea, Pauline Vetter, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 77
A Fourth Dose of COVID-19 Vaccine Does Not Induce Neutralization of the Omicron Variant Among Solid Organ Transplant Recipients With Suboptimal Vaccine Response
Andrew H. Karaba, Trevor S. Johnston, Tihitina Y. Aytenfisu, et al.
Transplantation (2022) Vol. 106, Iss. 7, pp. 1440-1444
Open Access | Times Cited: 67
From Alpha to Omicron: How Different Variants of Concern of the SARS-Coronavirus-2 Impacted the World
Mickensone Andre, Lee-Seng Lau, Marissa D. Pokharel, et al.
Biology (2023) Vol. 12, Iss. 9, pp. 1267-1267
Open Access | Times Cited: 43
Differences in the Concentration of Anti-SARS-CoV-2 IgG Antibodies Post-COVID-19 Recovery or Post-Vaccination
Andrzej Tretyn, Joanna Szczepanek, Monika Skorupa, et al.
Cells (2021) Vol. 10, Iss. 8, pp. 1952-1952
Open Access | Times Cited: 77
Menstrual abnormalities after COVID-19 vaccines: A systematic review
Maheen Nazir, Shumaila Asghar, Muhammad Ali Rathore, et al.
Vacunas (2022) Vol. 23, pp. S77-S87
Open Access | Times Cited: 65
COVID-19 mRNA booster vaccine induces transient CD8+ T effector cell responses while conserving the memory pool for subsequent reactivation
Matthias Reinscheid, Hendrik Luxenburger, Vivien Karl, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 57
A prospective study of the association between SARS-CoV-2 infection and COVID-19 vaccination with changes in usual menstrual cycle characteristics
Siwen Wang, Jasmine Mortazavi, Jaime E. Hart, et al.
American Journal of Obstetrics and Gynecology (2022) Vol. 227, Iss. 5, pp. 739.e1-739.e11
Open Access | Times Cited: 55
SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron
Alessio Mazzoni, Anna Vanni, Michele Spinicci, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 44
Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike
Andrew R. Crowley, Harini Natarajan, Andrew P. Hederman, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 43
SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies
Alessio Mazzoni, Anna Vanni, Michele Spinicci, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 6
Open Access | Times Cited: 39
The past, current and future epidemiological dynamic of SARS-CoV-2
François Balloux, Cedric C.S. Tan, Leo Swadling, et al.
Oxford Open Immunology (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 37
The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients
James L. Alexander, Benjamin H. Mullish, Nathan Danckert, et al.
EBioMedicine (2023) Vol. 88, pp. 104430-104430
Open Access | Times Cited: 36
Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens
Shona C. Moore, Barbara Kronsteiner, Stephanie Longet, et al.
Med (2023) Vol. 4, Iss. 3, pp. 191-215.e9
Open Access | Times Cited: 35
PLSCR1 is a cell-autonomous defence factor against SARS-CoV-2 infection
Dijin Xu, Weiqian Jiang, Lizhen Wu, et al.
Nature (2023) Vol. 619, Iss. 7971, pp. 819-827
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top